• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤特异性免疫的体外诱导。I. 细胞毒性淋巴细胞诱导和检测最佳条件的建立。

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.

作者信息

Burton R, Thompson J, Warner N L

出版信息

J Immunol Methods. 1975;8(1-2):133-49. doi: 10.1016/0022-1759(75)90090-3.

DOI:10.1016/0022-1759(75)90090-3
PMID:807654
Abstract

A microculture system for in vitro induction of tumour-specific immunity with syngeneic spleen cells and plasma-cell tumours is described. The system generates cytoxic lymphocytes assessed by their ability to lyse 51Cr-labelled target cells in a microcytotoxicity assay. Both the inductive and effector phases are subject to many variables in material and methodology and the optimal conditions are defined in this study. Of particular importance are the responder- to stimulator-cell ratios, the presence of 2-mercaptoethanol, the day of harvest, the method of target-cell 51Cr labelling, and preincubation of the cytotoxic lymphocytes prior to assay.

摘要

本文描述了一种用于体外诱导同基因脾细胞和浆细胞瘤肿瘤特异性免疫的微培养系统。该系统所产生的细胞毒性淋巴细胞通过在微细胞毒性试验中裂解51Cr标记靶细胞的能力来评估。诱导期和效应期在材料和方法上都存在许多变量,本研究确定了最佳条件。特别重要的是应答细胞与刺激细胞的比例、2-巯基乙醇的存在、收获日期、靶细胞51Cr标记方法以及细胞毒性淋巴细胞在测定前的预孵育。

相似文献

1
In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.肿瘤特异性免疫的体外诱导。I. 细胞毒性淋巴细胞诱导和检测最佳条件的建立。
J Immunol Methods. 1975;8(1-2):133-49. doi: 10.1016/0022-1759(75)90090-3.
2
A modified 51Cr release assay for cytotoxic lymphocytes.一种用于细胞毒性淋巴细胞的改良51铬释放试验。
J Immunol Methods. 1974 Dec;6(1-2):39-51. doi: 10.1016/0022-1759(74)90088-x.
3
Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.小鼠浆细胞瘤的肿瘤免疫。III. 通过体内和体外诱导肿瘤免疫反应检测BALB/c、C3H和NZB浆细胞瘤上常见和独特的肿瘤相关抗原。
J Natl Cancer Inst. 1977 Mar;58(3):701-9. doi: 10.1093/jnci/58.3.701.
4
Studies on the physiological manifestations of cell mediated cytotoxicity. II. Inhibition of (3-H)thymidine incorporation by plasmacytoma cells exposed in vitro to sensitized splenocytes.细胞介导细胞毒性的生理表现研究。II. 体外暴露于致敏脾细胞的浆细胞瘤细胞对(3-H)胸腺嘧啶核苷掺入的抑制作用。
Cell Immunol. 1975 May;17(1):181-91. doi: 10.1016/s0008-8749(75)80018-9.
5
Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.评估51铬释放以检测对化学诱导的大鼠实体瘤的细胞介导细胞毒性反应。
Br J Cancer. 1977 Jun;35(6):834-43. doi: 10.1038/bjc.1977.126.
6
In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique.利用末端标记技术进行的细胞介导细胞毒性的体外研究。
Cell Immunol. 1975 Feb;15(2):382-91. doi: 10.1016/0008-8749(75)90016-7.
7
In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.体外诱导肿瘤特异性免疫。I. 体外免疫小鼠淋巴细胞针对同基因和异基因浆细胞瘤的激活参数及细胞毒性反应性
J Exp Med. 1973 Jul 1;138(1):1-15. doi: 10.1084/jem.138.1.1.
8
Regulation of the immune response. VIII. Characteristics of antibody-mediated suppression of an in vitro cell-mediated immune response.免疫反应的调节。VIII. 抗体介导的体外细胞介导免疫反应抑制的特征。
Cell Immunol. 1975 Apr;16(2):330-47. doi: 10.1016/0008-8749(75)90122-7.
9
In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.体外诱导肿瘤特异性免疫:体内T淋巴细胞的要求及肿瘤生长抑制
Eur J Immunol. 1973 Aug;3(8):471-6. doi: 10.1002/eji.1830030804.
10
Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.佐剂性PC-5浆细胞瘤与同基因BALB/c脾细胞共有的一种诱导抑制性T细胞的抗原决定簇的证据。
Eur J Immunol. 1986 Jun;16(6):659-64. doi: 10.1002/eji.1830160612.

引用本文的文献

1
Two tumor models of curative adoptive chemoimmunotherapy using tumor-infiltrated spleen cells with potent antitumor cytotoxicity stimulated by antigen-sharing tumors.两种采用肿瘤浸润脾细胞进行根治性过继性化学免疫疗法的肿瘤模型,这些脾细胞由抗原共享肿瘤刺激产生,具有强大的抗肿瘤细胞毒性。
Cancer Immunol Immunother. 1993 Jul;37(2):89-96. doi: 10.1007/BF01517040.
2
Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.神经递质对针对同基因MOPC - 315浆细胞瘤的细胞毒性T淋巴细胞反应体外生成的抑制作用。
Cancer Immunol Immunother. 1995 Feb;40(2):79-87. doi: 10.1007/BF01520288.
3
An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.
基于Lyt抗原标志物和功能对肿瘤移植小鼠T淋巴细胞亚群的分析。
Immunology. 1982 Dec;47(4):663-77.
4
The early appearance of specific cytotoxic T cells in murine gut mucosa.小鼠肠道黏膜中特异性细胞毒性T细胞的早期出现。
Clin Exp Immunol. 1980 Nov;42(2):273-9.
5
Cytotoxic T cells in small intestine epithelial, lamina propria and lung lymphocytes.小肠上皮、固有层和肺淋巴细胞中的细胞毒性T细胞。
Immunology. 1981 Oct;44(2):367-71.
6
Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.携带大型MOPC-315肿瘤的小鼠脾脏中巨噬细胞对抗肿瘤免疫的抑制作用。
Cancer Immunol Immunother. 1984;16(3):162-9. doi: 10.1007/BF00205423.
7
Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.用T细胞生长因子和可溶性肿瘤提取物培养的荷瘤小鼠脾细胞的抗肿瘤及治疗作用
Cancer Immunol Immunother. 1984;18(3):215-22. doi: 10.1007/BF00205514.
8
Modulation of antitumor immunity--immunobiologic approaches.抗肿瘤免疫调节——免疫生物学方法。
Springer Semin Immunopathol. 1982;5(2):193-220. doi: 10.1007/BF00199796.
9
Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor.美法仑诱导肿瘤细胞免疫刺激能力增强,作为荷大转移灶MOPC - 315肿瘤小鼠脾脏中出现强效抗肿瘤免疫的一种机制。
Cancer Immunol Immunother. 1985;20(1):61-8. doi: 10.1007/BF00199775.
10
Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers.美法仑处理的MOPC - 315荷瘤小鼠脾脏细胞产生和表达增强的抗浆细胞瘤免疫的特异性
Cancer Immunol Immunother. 1986;23(1):11-9. doi: 10.1007/BF00205549.